Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Intestinal absorption-modifying excipients: A current update on preclinical in vivo evaluations
David Dahlgren, Markus Sjöblom, Hans Lennernäs
European Journal of Pharmaceutics and Biopharmaceutics (2019) Vol. 142, pp. 411-420
Closed Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Current hurdles to the translation of nanomedicines from bench to the clinic
Snežana Đorđević, María Medel, Inmaculada Conejos‐Sánchez, et al.
Drug Delivery and Translational Research (2021) Vol. 12, Iss. 3, pp. 500-525
Open Access | Times Cited: 224
Formulation strategies to improve the efficacy of intestinal permeation enhancers,
Sam Maher, David J. Brayden
Advanced Drug Delivery Reviews (2021) Vol. 177, pp. 113925-113925
Open Access | Times Cited: 64
Transient Permeation Enhancer® (TPE®) technology for oral delivery of octreotide: a technological evaluation
David J. Brayden, Sam Maher
Expert Opinion on Drug Delivery (2021) Vol. 18, Iss. 10, pp. 1501-1512
Open Access | Times Cited: 59
Safety of surfactant excipients in oral drug formulations
Sam Maher, Caroline Geoghegan, David J. Brayden
Advanced Drug Delivery Reviews (2023) Vol. 202, pp. 115086-115086
Open Access | Times Cited: 25
Parameterization of Physiologically Based Biopharmaceutics Models: Workshop Summary Report
Xavier Pépin, Sumit Arora, Luiza Borges, et al.
Molecular Pharmaceutics (2024)
Open Access | Times Cited: 7
Intestinal permeation enhancers to improve oral bioavailability of macromolecules: reasons for low efficacy in humans
Sam Maher, Caroline Geoghegan, David J. Brayden
Expert Opinion on Drug Delivery (2020) Vol. 18, Iss. 2, pp. 273-300
Open Access | Times Cited: 48
In silico screening of phenylethanoid glycosides, a class of pharmacologically active compounds as natural inhibitors of SARS-CoV-2 proteases
Caio Cheohen, Maria Eduarda Alves Esteves, Thamirys Silva da Fonseca, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 1461-1472
Open Access | Times Cited: 11
Intestinal permeation enhancers enable oral delivery of macromolecules up to 70 kDa in size
Katherine C. Fein, John P. Gleeson, Alexandra N. Newby, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2021) Vol. 170, pp. 70-76
Open Access | Times Cited: 25
Sodium glycodeoxycholate and sodium deoxycholate as epithelial permeation enhancers: in vitro and ex vivo intestinal and buccal bioassays
David J. Brayden, Vivien Stuettgen
European Journal of Pharmaceutical Sciences (2021) Vol. 159, pp. 105737-105737
Open Access | Times Cited: 24
Six years of progress in the oral biopharmaceutics area – A summary from the IMI OrBiTo project
Bertil Abrahamsson, Mark McAllister, Patrick Augustijns, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2020) Vol. 152, pp. 236-247
Open Access | Times Cited: 25
Effect of paracellular permeation enhancers on intestinal permeability of two peptide drugs, enalaprilat and hexarelin, in rats
David Dahlgren, Tobias Olander, Markus Sjöblom, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 6, pp. 1667-1675
Open Access | Times Cited: 23
Barriers to the Intestinal Absorption of Four Insulin-Loaded Arginine-Rich Nanoparticles in Human and Rat
Patrik Lundquist, Georgiy Khodus, Zhigao Niu, et al.
ACS Nano (2022) Vol. 16, Iss. 9, pp. 14210-14229
Open Access | Times Cited: 15
Role of MALDI-MSI in combination with 3D tissue models for early stage efficacy and safety testing of drugs and toxicants
Chloe E. Spencer, Lucy Flint, Catherine J. Duckett, et al.
Expert Review of Proteomics (2020) Vol. 17, Iss. 11-12, pp. 827-841
Open Access | Times Cited: 23
Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Metformin Hydrochloride
Melissa Metry, Yan Shu, Bertil Abrahamsson, et al.
Journal of Pharmaceutical Sciences (2021) Vol. 110, Iss. 4, pp. 1513-1526
Closed Access | Times Cited: 18
The In Vivo Effect of Transcellular Permeation Enhancers on the Intestinal Permeability of Two Peptide Drugs Enalaprilat and Hexarelin
David Dahlgren, Markus Sjöblom, Mikael Hedeland, et al.
Pharmaceutics (2020) Vol. 12, Iss. 2, pp. 99-99
Open Access | Times Cited: 20
Regional Intestinal Drug Permeability and Effects of Permeation Enhancers in Rat
David Dahlgren, M. J. Cano‐Cebrián, Tobias Olander, et al.
Pharmaceutics (2020) Vol. 12, Iss. 3, pp. 242-242
Open Access | Times Cited: 18
The progression of doxorubicin-induced intestinal mucositis in rats
Fredrik Kullenberg, Karsten Peters, Clara Luna-Marco, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2022) Vol. 396, Iss. 2, pp. 247-260
Open Access | Times Cited: 11
Long‐term daily oral administration of intestinal permeation enhancers is safe and effective in mice
Katherine C. Fein, John P. Gleeson, Kyle Cochran, et al.
Bioengineering & Translational Medicine (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 10
Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling to Support Waivers of In Vivo Clinical Studies: Current Status, Challenges, and Opportunities
Ioannis Loisios-Konstantinidis, Jennifer B. Dressman
Molecular Pharmaceutics (2020) Vol. 18, Iss. 1, pp. 1-17
Closed Access | Times Cited: 16
Effect of excipients on oral absorption process according to the different gastrointestinal segments
Alejandro Ruiz-Picazo, Isabel Lozoya-Agulló, Isabel González‐Álvarez, et al.
Expert Opinion on Drug Delivery (2020) Vol. 18, Iss. 8, pp. 1005-1024
Closed Access | Times Cited: 15
Intestinal absorption of BCS class II drugs administered as nanoparticles: A review based on in vivo data from intestinal perfusion models
David Dahlgren, Erik Sjögren, Hans Lennernäs
ADMET & DMPK (2020)
Open Access | Times Cited: 14
Investigations of Piperazine Derivatives as Intestinal Permeation Enhancers in Isolated Rat Intestinal Tissue Mucosae
Vivien Stuettgen, David J. Brayden
The AAPS Journal (2020) Vol. 22, Iss. 2
Closed Access | Times Cited: 13
Effect of Common Excipients on Intestinal Drug Absorption in Wistar Rats
Alejandro Ruiz-Picazo, Marta González‐Álvarez, Isabel González‐Álvarez, et al.
Molecular Pharmaceutics (2020) Vol. 17, Iss. 7, pp. 2310-2318
Closed Access | Times Cited: 13
A Critical Overview of the Biological Effects of Excipients (Part II): Scientific Considerations and Tools for Oral Product Development
Marilyn N. Martinez, Fang Wu, Bálint Sinkó, et al.
The AAPS Journal (2022) Vol. 24, Iss. 3
Closed Access | Times Cited: 5
Oral Drug Delivery, Absorption and Bioavailability
David Dahlgren, Hans Lennernäs
Elsevier eBooks (2021), pp. 406-437
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top